Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SSSS
SSSS logo

SSSS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy SuRo Capital Corp (SSSS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.290
1 Day change
1.45%
52 Week Range
13.480
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

SuRo Capital Corp (SSSS) does not present a strong buy opportunity for a beginner, long-term investor at this moment. While the stock has positive catalysts such as analyst upgrades and a shift to an externally managed structure, the lack of significant trading signals, insider selling, and poor financial performance in the latest quarter suggest caution. The investor may consider monitoring the stock for further developments or better entry points.

Technical Analysis

The technical indicators show mixed signals. The MACD is positive and contracting, suggesting a bullish trend, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the RSI is neutral at 71.107, and the pre-market price is down 0.38%, indicating no immediate upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Neutral
Option Volume Put-Call Ratio

The options data shows a balanced sentiment with no clear directional bias. The implied volatility is relatively low (IV Percentile: 25.2), and today's volume is significantly higher than the 30-day average, but this does not strongly indicate a bullish or bearish trend.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • Analysts have raised price targets to $15-$17, citing a shift to an externally managed structure and access to attractive private market opportunities.

  • The stock trades at a discount to its net asset value (NAV), with potential for further portfolio mark-ups.

Neutral/Negative Catalysts

  • Insiders are heavily selling, with a 22763.32% increase in selling activity over the last month.

  • The company's Q4 financials show significant declines in revenue (-370.49% YoY) and net income (-45308.78% YoY), indicating poor financial health.

  • No recent news or congress trading data to support positive sentiment.

Financial Performance

The company's Q4 2025 financials are weak, with revenue dropping to -$13.9M (-370.49% YoY) and net income falling to -$20.1M (-45308.78% YoY). EPS and gross margin remain flat at -0.8 and 0, respectively. This suggests significant financial challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are optimistic, with multiple firms raising price targets to $15-$17 and maintaining Outperform or Buy ratings. They cite the company's shift to an externally managed structure and potential NAV growth as key drivers.

Wall Street analysts forecast SSSS stock price to fall
3 Analyst Rating
Wall Street analysts forecast SSSS stock price to fall
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.290
sliders
Low
10.5
Averages
11.5
High
12
Current: 13.290
sliders
Low
10.5
Averages
11.5
High
12
BTIG
Buy
maintain
$15
AI Analysis
2026-04-09
Reason
BTIG
Price Target
$15
AI Analysis
2026-04-09
maintain
Buy
Reason
BTIG raised the firm's price target on SuRo Capital to $15 from $12.50 and keeps a Buy rating on the shares. The firm is citing the company's landmark partnership with an $18B asset manager that will see SuRo shift back to an externally-managed model, with the change not only reducing operating expenses but, more importantly, providing SuRo greater investment sourcing and due diligence capabilities, the analyst tells investors in a research note. This transaction will also enable SuRo shareholders to benefit from the asset manager's access to the most attractive, but hardest-to-access, private market opportunities, including AI infrastructure, the firm added.
Citizens
Devin Ryan
Outperform
maintain
$13 -> $15
2026-04-09
Reason
Citizens
Devin Ryan
Price Target
$13 -> $15
2026-04-09
maintain
Outperform
Reason
Citizens analyst Devin Ryan raised the firm's price target on SuRo Capital to $15 from $13 and keeps an Outperform rating on the shares. The firm notes the company announced two positive developments, including preliminary Q1 NAV of $14.00-$14.50 per share, which equates to an impressive 75%-plus increase from Q4 2025-end; and SuRo will be transitioning to an externally managed BDC from the current internally managed structure through a JV with Magnetar.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SSSS
Unlock Now

People Also Watch